China adjusts medical insurance to ease financial burden of COVID-19 patients
BEIJING -- Regional medical authorities in China are adjusting medical insurance policies to address the medical needs of COVID-19 patients.
These policies specified the medical insurance reimbursement rates for medical bills generated from COVID-19-related outpatient and inpatient treatment and online medical services.
In the meantime, local medical authorities in several provincial-level regions, including Beijing, Hubei, Guangxi, Yunnan and Anhui, have made a number of drugs used for treating COVID-19 infection symptoms reimbursable as well.
These adjustments have significantly relieved COVID-19 patients of their financial burdens. For instance, as per a new local policy introduced in East China's Anhui province in December, residents covered by medical insurance can have 70 percent of the fees generated from outpatient COVID-19 infection treatment reimbursed.
As of Tuesday, the medical bills from these outpatient treatments in the province totaled 3.69 million yuan (about $535,357), of which 2.41 million yuan was covered by medical insurance funds.
- Shanghai demonstrates ecological protection, building a green future
- Lithium battery spontaneously combusts on flight from Hangzhou in China to Seoul, no injuries reported
- China-EU university presidents' dialogue advances education
- Foreign vloggers immerse themselves in the cultural heritage of Shanxi
- Hunan's traditional crafts turn heads at Paris fashion show
- Company's initiatives highlight Xinjiang's shift to low-carbon gas transportation
